This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Desmonts, G Articles by Remington, J S Search for Related Content PubMed PubMed Citation Articles by Desmonts, G Articles by Remington, J S

 Previous Article  |  Next Article 

J Clin Microbiol. 1981 November; 14(5): 486-491

Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired Toxoplasma infections.

ABSTRACT

An immunoglobulin M (IgM)-immunosorbent agglutination assay (IgM-IS-AGA) was negative in all sera from individuals negative in the Sabin-Feldman dye test, in sera from individuals with chronic Toxoplasma infection, and in cord blood samples from uninfected infants. In contrast, all sera that were obtained from individuals with a recent history of acute Toxoplasma infection and from infants with congenital Toxoplasma infection and that were positive in both the dye test and the IgM-indirect fluorescent-antibody (IgM-IFA) test were positive in IgM-ISAGA. A total of 21 (67.7%) of 31 sera that were negative in the IgM-IFA test, despite being obtained from individuals with recently acquired Toxoplasma infection, and 8 (72.7%) of 11 sera that were negative in the IgM-IFA test and obtained from infants with congenital Toxoplasma infection were positive in IgM-ISAGA. The presence of rheumatoid factor, antinuclear antibodies, or both did not cause false-positive results in the IgM-ISAGA but did so in the IgM-IFA test. Thus, IgM-ISAGA in both more sensitive and more specific than the IgM-IFA test for detection of IgM antibodies to Toxoplasma gondii and, therefore, for the diagnosis of acute congenital and acquired Toxoplasma infections.

This article has been cited by other articles:

• Villena, I., Aubert, D., Brodard, V., Quereux, C., Leroux, B., Dupouy, D., Remy, G., Foudrinier, F., Chemla, C., Gomez-Marin, J. E., Pinon, J. M. (1999). Detection of Specific Immunoglobulin E during Maternal, Fetal, and Congenital Toxoplasmosis. J. Clin. Microbiol. 37: 3487-3490 [Abstract] [Full Text]  
• Jenum, P. A., Stray-Pedersen, B., Melby, K. K., Kapperud, G., Whitelaw, A., Eskild, A., Eng, J. (1998). Incidence of Toxoplasma gondii Infection in 35,940 Pregnant Women in Norway and Pregnancy Outcome for Infected Women. J. Clin. Microbiol. 36: 2900-2906 [Abstract] [Full Text]  
• Jenum, P. A., Stray-Pedersen, B. (1998). Development of Specific Immunoglobulins G, M, and A Following Primary Toxoplasma gondii Infection in Pregnant Women. J. Clin. Microbiol. 36: 2907-2913 [Abstract] [Full Text]  
• Martin, V., Arcavi, M., Santillan, G., Amendoeira, M. R. R., De Souza Neves, E., Griemberg, G., Guarnera, E., Garberi, J. C., Angel, S. O. (1998). Detection of Human Toxoplasma-Specific Immunoglobulins A, M, and G with a Recombinant Toxoplasma gondii Rop2 Protein. CVI 5: 627-631 [Abstract] [Full Text]